Young Caroline's Form 4 filing
Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 23, 2022
- Accession no.
- 0001209191-22-062657
- Filed
- Dec 23, 2022
- Trade date
- Dec 1-20, 2022
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market purchases total $848.69. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Young CarolineCIK 0001684087 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.33 | +$46.6 | 19,228 | Direct | |
| Dec 2, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.31 | +$46.2 | 19,248 | Direct | |
| Dec 5, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.19 | +$43.8 | 19,268 | Direct | |
| Dec 6, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.19 | +$43.8 | 19,288 | Direct | |
| Dec 7, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.18 | +$43.6 | 19,308 | Direct | |
| Dec 8, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.19 | +$43.8 | 19,328 | Direct | |
| Dec 9, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.15 | +$43 | 19,348 | Direct | |
| Dec 12, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.14 | +$42.8 | 19,368 | Direct | |
| Dec 13, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.18 | +$43.6 | 19,388 | Direct | |
| Dec 14, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.21 | +$44.2 | 19,408 | Direct | |
| Dec 15, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.24 | +$44.8 | 19,428 | Direct | |
| Dec 16, 2022 | Common Stock | PPurchaseAcquired | +20 | $2.22 | +$44.4 | 19,448 | Direct | |
| Dec 19, 2022 | Common Stock | PPurchaseAcquired | +30 | $2.21 | +$66.3 | 19,478 | Direct | |
| Dec 20, 2022 | Common Stock | PPurchaseAcquired | +109 | $2.31 | +$251.79 | 19,587 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.